NIMHANS launches neuropathy lecture series with support from Jenburkt Pharmaceuticals

NIMHANS has launched a Neuropathy Lecture Series to enhance the diagnosis and management of neuropathy, supported by a grant from Jenburkt Pharmaceuticals. This initiative aims to train primary care physicians through interactive sessions and educational materials. The series addresses the challenge of undiagnosed neuropathy, which can lead to chronic pain and disability. NIMHANS will provide doctors with tools to recognize symptoms, use diagnostic tests, and implement effective management strategies. Jenburkt Pharmaceuticals emphasizes its commitment to medical education and improving healthcare outcomes. The company aims to empower primary care physicians through initiatives like this lecture series, reinforcing the importance of informed medical practice.